Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TD7J
|
|||
| Drug Name |
ALKS 8700
|
|||
| Synonyms |
Diroximel fumarate; 1577222-14-0; 2-(2,5-Dioxopyrrolidin-1-yl)ethyl methyl fumarate; UNII-K0N0Z40J3W; K0N0Z40J3W; ALKS-8700; Diroximel Fumarete; Diroximel fumarate [INN]; ALKS8700; SCHEMBL15499960; CHEMBL3989944; SCHEMBL15511916; Diroximel fumarate [USAN:INN]; RDC5108; MolPort-046-033-659; Diroximel Fumarete(ALKS-8700); RDC-5108; ZINC215286156; AKOS027256112; AS-55046; TZ001258; 2-(2,5-Dioxopyrrolidin-1-yl)ethyl methyl (2E)-but- 2-enedioate; 2-Butenedioic acid (2E)-, 1-(2-(2,5-dioxo-1-pyrrolidinyl)ethyl) 4-methyl ester
Click to Show/Hide
|
|||
| Indication | Multiple sclerosis [ICD-11: 8A40; ICD-9: 340] | Phase 3 | [1] | |
| Company |
Alkermes, Waltham, MA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H13NO6
|
|||
| Canonical SMILES |
COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O
|
|||
| InChI |
1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+
|
|||
| InChIKey |
YIMYDTCOUQIDMT-SNAWJCMRSA-N
|
|||
| CAS Number |
CAS 1577222-14-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.